2015 American Transplant Congress » Poster Session A: Late Breaking

5:30pm-7:30pm

Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost-Differential in Treatment of AMR

R. Banga,¹ C. Schinstock,¹ A. Boscoe,⁴ M. Hathcock,³ W. Kremers,³ M. Stegall.²

5:30pm-7:30pm

Clinical Outcome of Patients With De Novo C1q Binding Donor-Specific HLA Antibodies After Renal Transplantation

J. Bamoulid,¹ A. Roodenburg,² O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹

5:30pm-7:30pm

Clinical and Immunologic Risk Factors Associated With Donor-Specific Antibody (DSA) Formation Following Renal Transplantation

C. Johnson,¹ S. Park,¹ J. Schiller.²

5:30pm-7:30pm

DSA Monitoring in Kidney Transplant Recipients

F. Pean,¹ M. Cooper,¹ J. Verbesey,¹ A. Gilbert,¹ B. Javaid,¹ R. Mohammed,¹ O. Timofeeva,² J. Moore,¹ K. Cruz,¹ R. Ghasemian,¹ T. Fishbein,¹ M. Grafals.¹

5:30pm-7:30pm

Early Antibody Mediated Rejection in HLA Antibody Incompatible Kidney Transplantation – A Treatable Condition Without Heavy Induction Immunosuppression

S. Daga,^1,2 N. Krishnan,¹ D. Lowe,³ F. Lam,¹ C. Imray,^1,2 H. Kashi,¹ L. Tan,¹ D. Briggs,³ R. Higgins.^1,2

5:30pm-7:30pm

Gene Expression Monitoring in Pediatric Heart Transplant Recipients

C. Sutton,¹ R. Butts,² A. Burnette,³ A. Savage,² W. Uber,¹ A. Haney.¹

5:30pm-7:30pm

Impact of Anti-CMV Prophylactic Therapy on the Development of CMV Quantiferon Sero-Conversion in High-Risk Patients

A. Palanisamy, D. Taber, N. Pilch, C. Bratton, J. McGillicuddy, P. Baliga, K. Chavin.

5:30pm-7:30pm

Responsiveness to Rituximab, Plasmapheresis and Intravenous Immunoglobulins in Antibody Mediated Rejections After Kidney and Pancreas – Kidney Transplantation

E. Minué,¹ L. León,¹ P. Uva,¹ A. Dotta,¹ J. Walther,¹ O. Casanova,¹ F. Togniolo,¹ O. Guardia,¹ M. Rial,¹ E. Chuluyan,² D. Casadei.¹